Nyxoah SA (NYXH) Form 6-K — Jun 8, 2026
Nyxoah SA has entered into an underwriting agreement for a public offering of 55.2 million ordinary shares at $1.72 per share, raising approximately $88.5 million in net proceeds. The offering includes a 30-day over-allotment option for an additional 8.3 million shares, bringing the total potential issuance to 63.5 million shares. The capital raise is significant for the Belgian medical device company, which is listed on Nasdaq and Euronext Brussels. The low share price of $1.72 and the substantial dilution suggest the company is raising funds to support operations or growth initiatives, potentially signaling cash flow pressures or aggressive expansion plans.
Key figures
- Gross Proceeds
- 95000000
- Offering Price
- 1.72
- Shares Offered
- 55232558
- Net Proceeds
- 88500000
- Option Shares
- 8284883
- Underwriting Discount Per Share
- 0.1032
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.